The long-term goal of this project is to elucidate the cellular mechanisms of renal calcium transport and its regulation by parathyroid hormone (PTH). PTH-dependent renal calcium transport proceeds in distal nephron segments comprising cortical thick ascending limbs and distal convoluted tubules. The effects of PTH are mediated by the type I PTH receptor (PTH1R). The magnitude and duration of PTH action is ultimately linked to the balance between signal generation and signal termination by its cognate receptor, the Type I PTH/PTHrP receptor (PTH1R). Although the mechanism of PTH1R-mediated stimulation of renal calcium absorption is reasonably well understood, the events involved in and the mechanism by which PTH action is terminated in target kidney cells is not known. The PTH1R exhibits distal nephron cell-specific signaling that involves phospholipase D (PLD) and mitogen-activated protein kinase (MAPK). However, the mechanism by which the PTH1R signals through these pathways is unknown. Finally, although great strides have been made in generating transgenic mice harboring PTH1R or other relevant receptor or calcium channel mutations, it is not known how these proteins function in the intact animal to govern renal calcium homeostasis.
Three Specific Aims have been developed to address these deficiencies.
Aim 1 will characterize PTH1R internalization, desensitization, and recycling in distal tubule cells. This will be achieved by defining the ligand and receptor structural determinants required for these actions. Experiments will be performed to study internalization and desensitization of wild-type and phosphorylation-deficient PTH1R mutants using incrementally truncated PTH peptides that we show exhibit ligand- and cell-specific induction of receptor internalization.
In Aim 2, PTH1R cell-specific signaling in distal tubule cells will be analyzed by determining the mechanism of PTH activation of phospholipase D (PLD); defining the role of PTH-stimulated PLD activity in mitogen-activated protein kinase (MAPK) activation; and characterizing the requirement for PTH1R internalization in MAPK activation.
Aim 3 will extend and integrate the questions from the cell and molecular level to an analysis of PTH1R-mediated calcium transport in mice harboring PTH1R signaling mutations, by evaluating the effect of calcium-sensing receptors (CaSR) on PTH-dependent calcium absorption, and defining the role of calcium channel beta-subunits in PTH-stimulated calcium transport. Single microperfused tubules and renal clearance techniques will be applied. The proposed studies will provide novel and important information on the mechanism and role by which the PTH1R regulates renal calcium absorption. The results will provide greater understanding of the initiation and termination of PTH1R action on renal calcium absorption. The outcomes may suggest additional pathophysiological mechanisms causing PTH resistance and lead to new treatment opportunities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK054171-21
Application #
7064800
Study Section
Special Emphasis Panel (ZRG1-SSS-M (05))
Program Officer
Ketchum, Christian J
Project Start
1998-09-01
Project End
2008-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
21
Fiscal Year
2006
Total Cost
$417,136
Indirect Cost
Name
University of Pittsburgh
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Pavlos, Nathan J; Friedman, Peter A (2017) GPCR Signaling and Trafficking: The Long and Short of It. Trends Endocrinol Metab 28:213-226
Pereira, Renata C; Andersen, Thomas L; Friedman, Peter A et al. (2016) Bone Canopies in Pediatric Renal Osteodystrophy. PLoS One 11:e0152871
McGarvey, Jennifer C; Xiao, Kunhong; Bowman, Shanna L et al. (2016) Actin-Sorting Nexin 27 (SNX27)-Retromer Complex Mediates Rapid Parathyroid Hormone Receptor Recycling. J Biol Chem 291:10986-1002
Walsh, Dustin R; Nolin, Thomas D; Friedman, Peter A (2015) Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins. Pharmacol Rev 67:656-80
Stubbs, Jason R; Zhang, Shiqin; Friedman, Peter A et al. (2014) Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD. Clin J Am Soc Nephrol 9:1965-73
Alonso, Veronica; Friedman, Peter A (2013) Minireview: ubiquitination-regulated G protein-coupled receptor signaling and trafficking. Mol Endocrinol 27:558-72
Liu, Li; Schlesinger, Paul H; Slack, Nicole M et al. (2011) High capacity Na+/H+ exchange activity in mineralizing osteoblasts. J Cell Physiol 226:1702-12
Alonso, VerĂ³nica; Magyar, Clara E; Wang, Bin et al. (2011) Ubiquitination-deubiquitination balance dictates ligand-stimulated PTHR sorting. J Bone Miner Res 26:2923-34
Blair, Harry C; Robinson, Lisa J; Huang, Christopher L-H et al. (2011) Calcium and bone disease. Biofactors 37:159-67
Ardura, Juan A; Wang, Bin; Watkins, Simon C et al. (2011) Dynamic Na+-H+ exchanger regulatory factor-1 association and dissociation regulate parathyroid hormone receptor trafficking at membrane microdomains. J Biol Chem 286:35020-9

Showing the most recent 10 out of 41 publications